Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorMelphalanCombined Modality TherapyLeukapheresisAntigens, CD34Hematologic NeoplasmsStem Cell TransplantationBlood Component RemovalMultiple MyelomaCyclophosphamideBone Marrow TransplantationAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseBusulfanMyeloablative AgonistsTreatment OutcomeGranulocytesGraft SurvivalLymphoma, Non-HodgkinHematopoietic Stem CellsEtoposideRemission InductionAntineoplastic Agents, AlkylatingRecurrenceThiotepaCarmustineSalvage TherapyCytophagocytosisVincristineIfosfamideHematopoiesisCytarabineHodgkin DiseaseDisease-Free SurvivalStem CellsAmyloidosisCord Blood Stem Cell TransplantationTransplantation ChimeraRetrospective StudiesTissue DonorsWhole-Body IrradiationSurvival RateSurvival AnalysisNeoplasmsTime FactorsLiver TransplantationDoxorubicinInfectionImmunosuppressive AgentsHistocompatibilityLymphoma, T-CellBone Marrow PurgingPrednisonePlatelet CountHistocompatibility TestingLeukemia, Myeloid, AcuteTransplantation, IsogeneicPOEMS SyndromeDexamethasoneFollow-Up StudiesRecombinant ProteinsCarboplatinLeukemiaBlood Cell CountVidarabineLymphomaAntineoplastic AgentsFeasibility StudiesProspective StudiesKidney TransplantationBlood CellsCytomegalovirus InfectionsBlood Transfusion, AutologousMyelodysplastic SyndromesGraft vs Leukemia EffectFatal OutcomeBone MarrowCell TransplantationAnemia, AplasticImmunophenotypingPrognosisT-LymphocytesCell SeparationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionImmunosuppressionLeukocytes, MononuclearHLA AntigensCyclosporineHematologic DiseasesTransplantation ImmunologyMesenchymal Stem Cell TransplantationCells, CulturedBone Marrow Cells